Central Retinal and Posterior Ciliary Artery Occlusion After Intralesional Injection of Sclerosant to Glabellar Subcutaneous Hemangioma

被引:0
作者
Toshihiko Matsuo
Hiroyasu Fujiwara
Hideo Gobara
Hidefumi Mimura
Susumu Kanazawa
机构
[1] Okayama University Graduate School of Medicine,Department of Ophthalmology
[2] Dentistry,Department of Radiology
[3] and Pharmaceutical Sciences,undefined
[4] Okayama University Graduate School of Medicine,undefined
[5] Dentistry,undefined
[6] and Pharmaceutical Sciences,undefined
来源
CardioVascular and Interventional Radiology | 2009年 / 32卷
关键词
Facial (glabellar) hemangioma; Sclerosing therapy; Sclerotherapy; Sclerosant; Polidocanol; Central retinal artery occlusion; Posterior ciliary artery occlusion;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study is to describe vision loss caused by central retinal artery and posterior ciliary artery occlusion as a consequence of sclerotherapy with a polidocanol injection to a glabellar hemangioma. An 18-year-old man underwent direct injection with a 23-gauge needle of 1 mL of a polidocanol-carbon dioxide emulsion into the glabellar subcutaneous hemangioma under ultrasound visualization of the needle tip by radiologists. He developed lid swelling the next day, and 3 days later at referral, the visual acuity in the left eye was no light perception. Funduscopy revealed central retinal artery occlusion and fluorescein angiography disclosed no perfusion at all in the left fundus, indicating concurrent posterior ciliary artery occlusion. The patient also showed mydriasis, blepharoptosis, and total external ophthalmoplegia on the left side. Magnetic resonance imaging demonstrated the swollen medial rectus muscle. In a month, blepharoptosis and ophthalmoplegia resolved but the visual acuity remained no light perception. Sclerosing therapy for facial hemangioma may develop a severe complication such as permanent visual loss.
引用
收藏
页码:341 / 346
页数:5
相关论文
共 105 条
[1]  
Tisi PV(2006)Injection sclerotherapy for varicose veins Cochrane Database Syst Rev 4 CD001732-336
[2]  
Beverley C(1995)The Australian polidocanol (aethoxysklerol) study. Results at 2 years Dermatol Surg 21 334-649
[3]  
Rees A(1990)Sclerosants for variceal sclerotherapy: a critical appraisal Am J Gastroenterol 85 641-12
[4]  
Conrad P(1999)Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study Gastrointest Endosc 50 7-127
[5]  
Malouf GM(1992)Sclerotherapy of internal hemorrhoids using newly devised transparent disposable anorectoscope Surg Endosc 6 125-412
[6]  
Stacey MC(2004)Efficacy of endoscopic clipping for actively bleeding peptic ulcer: comparison with polidocanol injection therapy Hepatogastroenterology 51 408-469
[7]  
Sarin SK(1987)Treatment of hemangiomas by sclerosing agents: an experimental and clinical study Ann Plast Surg 18 465-549
[8]  
Kumar A(1987)Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions Plast Reconstr Surg 79 542-90
[9]  
Umehara M(1988)The treatment of facial haemangioma by percutaneous injections of sodium tetradecyl sulfate J Laryngol Otol 102 87-29
[10]  
Onda M(1991)Treatment of angiomas with sclerosing injection of hydroxypolyethoxydodecan Angiology 42 23-209